Z6尊龙

	Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
	YOU SHOULD READ THE WARNING IN THE DOCUMENT.

? Warning ? Important ? Expected Timetable ? Contents ? Summary ? Definitions ? Glossary of Technical Terms ? Forward-looking Statements ? Risk Factors ? Waivers and Consents from Strict Compliance with the Hong Kong Listing Rules ? Information about this Document and the [REDACTED] ? Directors, Supervisors and Parties Involved in the [REDACTED] ? Corporate Information ? Industry Overview ? Regulatory Environment ? History, Development and Corporate Structure ? Business ? Relationship with the Controlling Shareholders ? Connected Transaction ? Directors, Supervisors and Senior Management ? Share Capital ? Substantial Shareholders ? [REDACTED] ? Financial Information ? Future Plans and Use of [REDACTED] ? [REDACTED] ? Structure of the [REDACTED] ? How to Apply for the [REDACTED] ? Appendix I - Accountants' Report ? Appendix IA - Report on Review of Interim Condensed Consolidated Financial Information for the Three Months Ended March 31, 2020 ? Appendix II - [REDACTED] ? Appendix III - Taxation and Foreign Exchange ? Appendix IV - Summary of Principal Legal and Regulatory Provisions ? Appendix V - Summary of Articles of Association ? Appendix VI - Statutory and General Information ? Appendix VII - Documents Delivered to the Registrar of Companies in Hong Kong and Available for Inspection